Yeaman Kevin J's Form 4 filing
Dolby Laboratories, Inc.DLB · filed Jun 25, 2024
- Accession no.
- 0000950170-24-077565
- Filed
- Jun 25, 2024
- Trade date
- Jun 17, 2024
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $200.06. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeaman Kevin JCIK 0001200469 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Class A Common Stock | PPurchaseAcquired | +2.56 | $78.15 | +$200.06 | 2.56 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.